CLASS | MOLPATH | LP7822-2 |
COMPONENT | Comment on fetal Angelman syndrome risk | LP185991-9 |
PROPERTY | Txt | LP6885-0 |
TIME_ASPCT | Pt | LP6960-1 |
SYSTEM | WBC.DNA+Plas.cfDNA | LP185797-0 |
SCALE_TYP | Nar | LP7749-7 |
METHOD_TYP | Dosage of chromosome specific cf DNA | LP172871-8 |
parent | Comment on fetal Angelman syndrome risk | Plasma cell-free+WBC DNA | Molecular pathology | LP401849-7 |
CLASSTYPE | Laboratory class | |
ORDER_OBS | Both |
LONG_COMMON_NAME | en-US | Comment on fetal Angelman syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
LONG_COMMON_NAME | en-US | Comment on fetal Angelman syndrome risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative |
SHORTNAME | en-US | Fet AS risk comment |
ConsumerName | en-US | Comment on Angelman syndrome risk |
LONG_COMMON_NAME | fr-FR | Risque syndrome d'Angelman foetal (commentaire du conseiller génétique) [Texte] Leucocytes ADN+Plasma avec ADN libre circulant ; Résultat textuel ; Dosage d'ADN libre circulant spécifiques aux chromosomes |
LONG_COMMON_NAME | es-MX | Comentario del consejero genético sobre el riesgo de síndrome de Angelman fetal: Libre de células plasmáticas + ADN de leucocitos : Punto temporal: Texto: Narrativo: Dosis de cfDNA cromosómico específico |
LOINC Version: 2.77